-
Metabolism of Sumatriptan Revisited: CYP and MAO
2026-09-18
Pöstges and Lehr revisited the accepted metabolic pathway of sumatriptan using recombinant human cytochrome P450 and monoamine oxidase enzymes with HPLC–MS analysis. Their results show that CYP1A2, CYP2C19, and CYP2D6 can initiate N-demethylation, while MAO A further oxidatively deaminates sumatriptan and its desmethyl metabolites, indicating that the pathways are complementary rather than mutually exclusive.
-
Methoxy-X04 for Mechanism-Resolved Aβ Imaging
2026-09-18
Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe for resolving plaque, oligomeric, and cerebrovascular amyloid signals in Alzheimer’s models. This article presents an assay framework that connects amyloid imaging with rTMS-driven microglial clearance while separating fluorescence changes from claims about mechanism.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-09-17
The Tricine-SDS-PAGE Gel Preparation Kit is intended for researchers who need improved resolution of low-molecular-weight proteins and peptides that can be difficult to resolve with conventional Tris-SDS-PAGE. It supports denaturing or non-denaturing electrophoresis workflows when sample preparation and running conditions are selected appropriately, but it is intended only for scientific research and not for diagnostic or medical use.
-
NRF2–ATF4 Stress Signaling in Pancreatic Cancer
2026-09-17
A 2026 study shows that Se-methylselenocysteine produces phenotype-dependent redox remodeling in pancreatic ductal adenocarcinoma, with KYAT1 expression shaping metabolic activation and treatment response. The work connects NRF2 and ATF4 stress signaling with lipid peroxidation and ferroptosis-associated changes, providing a framework for studying oxidative vulnerabilities and cancer therapeutic resistance.
-
Cy7 NHS Ester: Practical Labeling and QC
2026-09-16
Cy7 NHS ester (SKU A8109) is a water-soluble Sulfo-Cy7 NHS Ester for labeling accessible primary amines on proteins, peptides, and related biomolecules for near-infrared fluorescent imaging. It is well suited to aqueous workflows involving sensitive biomolecules, but it should not be selected for targets lacking accessible amino groups or for long-term storage of prepared dye solutions.
-
Clozapine N-oxide (CNO) in Reliable Cell Assays
2026-09-16
This scenario-based guide explains how Clozapine N-oxide (CNO), SKU A3317, can be integrated into DREADD-enabled viability, proliferation, and cytotoxicity workflows. It covers controls, solvent compatibility, stock handling, interpretation, and practical criteria for selecting a reliable research-grade source.
-
MLKL Polymerization Drives Lysosomal Permeabilization
2026-09-15
The reference study identifies lysosomal membrane permeabilization as a key execution step linking MLKL polymerization to necroptotic cell death. Using live-cell imaging, lysosomal leakage assays, and cathepsin B perturbation, it shows that MLKL-dependent lysosomal damage precedes plasma membrane rupture and promotes proteolytic destruction of survival factors.
-
Aurora A Overexpression in Retinoblastoma
2026-09-15
The 2024 American Journal of Pathology study identifies AURKA overexpression as a recurrent feature of human retinoblastoma and links it to histopathologic factors associated with high-risk disease. By combining patient specimens, genetic depletion, pharmacologic inhibition, xenografts, and patient-derived material, the work supports AURKA as a biologically relevant therapeutic target while also defining important limits for translation.
-
Recombinant Human EGF in Cancer Assays
2026-09-14
Explore how Epidermal Growth Factor and recombinant human EGF can be used as controlled assay variables in proliferation, apoptosis, and MYC-driven cancer research. This article connects EGF receptor biology with the EphA2 synthetic-lethality study while emphasizing experimental controls, product quality, and interpretation limits.
-
Angiotensin I/II (1-5): RAS Workflow Guide
2026-09-14
This guide explains how to prepare, handle, and quality-check Angiotensin I/II (1-5), an Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research. It is appropriate for cardiovascular, renal, blood pressure, and aldosterone-focused workflows, but should not be generalized to unrelated signaling studies without independent validation.
-
3-Deazaadenosine in Methylation Assays
2026-09-13
3-Deazaadenosine is an S-adenosylhomocysteine hydrolase inhibitor for experimentally perturbing SAM-dependent methylation. This article explains how to use it alongside METTL14-centered assays to separate global methylation effects from locus-specific epitranscriptomic mechanisms.
-
FPS-ZM1: RAGE Signaling Beyond Alzheimer’s
2026-09-12
FPS-ZM1 is a selective RAGE inhibitor for separating receptor-dependent amyloid beta signaling from broader metabolic and inflammatory effects. This article converts recent RAGE/POMC findings into a causality-focused assay strategy for Alzheimer’s disease research and neuroinflammation studies.
-
MLKL Polymerization and Lysosomal Permeabilization
2026-09-11
The reference study identifies lysosomal membrane permeabilization as a key execution step in MLKL-driven necroptosis. Using live-cell imaging, MLKL-domain experiments, and cathepsin B perturbation, the authors connect MLKL polymerization to lysosomal disruption, cytosolic protease release, and cell death.
-
Iron Stress Reprograms Enterocyte Metabolism
2026-09-11
Navazesh and Ji used paired iron-deficiency and iron-excess perturbations in IPEC-J2 enterocytes to show that iron availability reshapes transcription, inflammation, proliferation, and intermediary metabolism. The study’s repletion experiment further indicates that some iron-stress metabolic changes are reversible, providing a useful framework for intestinal nutrition and barrier-function research.
-
DNA Removal as a Translational Control Point
2026-09-10
Clean nucleic-acid workflows are not merely technical housekeeping: they shape how confidently researchers interpret organoid, co-culture, RT-PCR, and transcription data. This thought-leadership article connects DNase I mechanism with the patient-specific pancreatic cancer organoid–fibroblast study by Schuth et al., then provides a strategic framework for deploying ribonuclease-free DNase I in translational workflows.